Robert E. Gallagher

11.7k total citations · 4 hit papers
98 papers, 7.8k citations indexed

About

Robert E. Gallagher is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Robert E. Gallagher has authored 98 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 47 papers in Hematology and 20 papers in Genetics. Recurrent topics in Robert E. Gallagher's work include Retinoids in leukemia and cellular processes (52 papers), Acute Myeloid Leukemia Research (44 papers) and Virus-based gene therapy research (16 papers). Robert E. Gallagher is often cited by papers focused on Retinoids in leukemia and cellular processes (52 papers), Acute Myeloid Leukemia Research (44 papers) and Virus-based gene therapy research (16 papers). Robert E. Gallagher collaborates with scholars based in United States, United Kingdom and Canada. Robert E. Gallagher's co-authors include Robert C. Gallo, Steven Collins, Francis W. Ruscetti, Peter H. Wiernik, K. B. McCredie, R. C. Ting, Richard S. Metzgar, Michael J. Ahearn, S Tsai and Gurmit S. Aulakh and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert E. Gallagher

97 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

1977 1.9k citations Steven Collins, Robert C. Gallo et al. profile →
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

1978 1.4k citations Steven Collins, Francis W. Ruscetti et al. profile →
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia

1979 796 citations Robert E. Gallagher, Steven Collins et al. Blood profile →
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.

1979 530 citations Steven Collins, Francis W. Ruscetti et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert E. Gallagher United States	36	5.0k	2.3k	1.6k	1.1k	1.0k	98	7.8k
Ralph B. Arlinghaus United States	51	5.4k 1.1×	3.0k 1.3×	1.1k 0.7×	1.9k 1.8×	1.3k 1.2×	250	10.7k
Keith K. Stanley Australia	43	3.4k 0.7×	454 0.2×	1.4k 0.8×	521 0.5×	678 0.7×	103	7.4k
Eugene L. Brown United States	31	4.8k 1.0×	1.2k 0.5×	930 0.6×	774 0.7×	1.2k 1.1×	50	7.6k
D Santoli United States	39	1.9k 0.4×	929 0.4×	3.5k 2.2×	1.3k 1.3×	629 0.6×	111	6.6k
Marc Piechaczyk France	48	6.5k 1.3×	854 0.4×	1.9k 1.2×	2.0k 1.9×	1.4k 1.3×	141	10.2k
Michiko N. Fukuda United States	55	6.3k 1.3×	708 0.3×	2.8k 1.7×	550 0.5×	561 0.5×	162	8.8k
Katherine L. B. Borden Canada	53	6.6k 1.3×	645 0.3×	1.2k 0.8×	930 0.9×	666 0.6×	118	8.2k
Carl G. Gahmberg Finland	63	6.5k 1.3×	2.2k 1.0×	4.3k 2.7×	1.3k 1.2×	829 0.8×	267	13.5k
Thomas J. Gonda Australia	46	5.4k 1.1×	1.2k 0.5×	2.5k 1.5×	3.0k 2.8×	1.2k 1.2×	125	9.2k
Lawrence W. Stanton Singapore	53	6.9k 1.4×	346 0.2×	1.3k 0.8×	680 0.6×	1.1k 1.0×	124	10.4k

Countries citing papers authored by Robert E. Gallagher

Since Specialization

Citations

This map shows the geographic impact of Robert E. Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Gallagher more than expected).

Fields of papers citing papers by Robert E. Gallagher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Gallagher. The network helps show where Robert E. Gallagher may publish in the future.

Co-authorship network of co-authors of Robert E. Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Gallagher. A scholar is included among the top collaborators of Robert E. Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Gallagher. Robert E. Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gillespie, James B., Tamíris Pacheco da Costa, Xavier Cama-Moncunill, et al.. (2023). Real-Time Anomaly Detection in Cold Chain Transportation Using IoT Technology. Sustainability. 15(3). 2255–2255. 35 indexed citations

Poiré, Xavier, Barry Kurt Moser, Robert E. Gallagher, et al.. (2013). Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype. Leukemia & lymphoma. 55(7). 1523–1532. 38 indexed citations

Liu, Xiaomei, Enrique Carrillo de Santa Pau, Pamela D. Unger, et al.. (2012). KLF6 Loss of Function in Human Prostate Cancer Progression Is Implicated in Resistance to Androgen Deprivation. American Journal Of Pathology. 181(3). 1007–1016. 23 indexed citations

Gore, Steven D., Ivana Gojo, Mikkael A. Sekeres, et al.. (2010). Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia. Journal of Clinical Oncology. 28(6). 1047–1053. 69 indexed citations

Guo, Yongli, Bruce A. Stanton, Jennifer M. Bomberger, et al.. (2010). Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia. Cancer Research. 70(23). 9875–9885. 52 indexed citations

Slack, James L. & Robert E. Gallagher. (2007). The molecular biology of acute promyelocytic leukemia. Cancer treatment and research. 99. 75–124. 8 indexed citations

Stock, Wendy, Richard C. Harvey, Barry Kurt Moser, et al.. (2006). Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.. Blood. 108(11). 494–494. 2 indexed citations

Stock, Wendy, Barry Kurt Moser, Dorie A. Sher, et al.. (2006). PML-RARα isoform at diagnosis is associated with disease-free survival (DFS) in patients enrolled in the intergroup trial (C-9710) for treatment of acute promyelocytic leukemia (APL). Journal of Clinical Oncology. 24(18_suppl). 6504–6504. 3 indexed citations

Gallagher, Robert E.. (2005). Dueling mutations in normal karyotype AML. Blood. 106(12). 3681–3682. 9 indexed citations

10.

Sun, Yi, D-C Zhou, Wei Ding, et al.. (2004). Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide. Leukemia. 18(7). 1258–1269. 14 indexed citations

11.

Gallagher, Robert E., Anna C. Ferrari, Andreas Kaubisch, et al.. (2004). Arsenic trioxide (ATO) in metastatic hormone-refractory prostate cancer (HRPC): Results of phase II trial T99–0077. Journal of Clinical Oncology. 22(14_suppl). 4638–4638. 3 indexed citations

12.

Wiernik, Peter H., Nancy Sun, Deborah Thompson, et al.. (1994). Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: Increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease. Leukemia Research. 18(10). 741–748. 12 indexed citations

13.

Paietta, Elisabeth, J. Andersen, Robert E. Gallagher, et al.. (1994). The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.. PubMed. 8(7). 1108–12. 103 indexed citations

14.

Hogge, Donna E., et al.. (1990). Low dose 5-azacytidine is ineffective for remission induction in patients with acute myeloid leukemia.. PubMed. 4(12). 835–8. 14 indexed citations

15.

Wersto, Robert P., F. Herz, Robert E. Gallagher, & Leopold G. Koss. (1988). Cell cycle-dependent reactivity with the monoclonal antibody Ki-67 during myeloid cell differentiation. Experimental Cell Research. 179(1). 79–88. 60 indexed citations

16.

Gallagher, Robert E., et al.. (1985). Characterization of differentiation-inducer-resistant HL-60 cells. Leukemia Research. 9(8). 967–986. 34 indexed citations

17.

Gallagher, Robert E. & R. Joseph. (1982). Nonlinguistic Knowledge, Hemispheric Laterality, and the Conservation of Inequality in Nonconserving Children. The Journal of General Psychology. 107(1). 31–40. 7 indexed citations

18.

Collins, Steven, Francis W. Ruscetti, Robert E. Gallagher, & Robert C. Gallo. (1979). Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.. The Journal of Experimental Medicine. 149(4). 969–974. 530 indexed citations breakdown →

19.

Gallo, Robert C., Robert E. Gallagher, M. G. Sarngadharan, et al.. (1974). The evidence for involvement of type C RNA tumor viruses in human acute leukemia. Cancer. 34(S8). 1398–1405. 15 indexed citations

20.

Gallagher, Robert E., Robert C. Ting, & Robert C. Gallo. (1972). A common change of aspartyl-tRNA in polyoma- and SV40-transformed cells. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 272(4). 568–582. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact